Healthcare provider profile · identity verified

Jeff A D'Amico, DO

Internal Medicine · ELMHURST, IL · NPI 1639350978

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	276	77
Atorvastatin Calcium	Atorvastatin Calcium	259	73
Levothyroxine Sodium	Levothyroxine Sodium	233	63
Rosuvastatin Calcium	Rosuvastatin Calcium	186	68
Lisinopril	Lisinopril	159	50
Sertraline Hcl	Sertraline Hcl	151	20
Jardiance	Empagliflozin	150	46
Simvastatin	Simvastatin	147	26
Tamsulosin Hcl	Tamsulosin Hcl	138	51
Furosemide	Furosemide	136	51
Omeprazole	Omeprazole	136	50
Citalopram Hbr	Citalopram Hydrobromide	132	suppressed
Amlodipine Besylate	Amlodipine Besylate	130	40
Gabapentin	Gabapentin	127	47
Famotidine	Famotidine	126	19
Pantoprazole Sodium	Pantoprazole Sodium	122	46
Xarelto	Rivaroxaban	114	14
Allopurinol	Allopurinol	110	27
Losartan Potassium	Losartan Potassium	110	41
Escitalopram Oxalate	Escitalopram Oxalate	106	29
Memantine Hcl	Memantine Hcl	93	18
Pravastatin Sodium	Pravastatin Sodium	92	26
Hydrochlorothiazide	Hydrochlorothiazide	91	14
Metoprolol Tartrate	Metoprolol Tartrate	89	30
Prednisone	Prednisone	86	46
Finasteride	Finasteride	84	14
Metformin Hcl	Metformin Hcl	84	30
Spironolactone	Spironolactone	78	18
Trazodone Hcl	Trazodone Hcl	77	12
Eliquis	Apixaban	75	20
Buspirone Hcl	Buspirone Hcl	71	suppressed
Mirtazapine	Mirtazapine	71	14
Alprazolam	Alprazolam	65	19
Meloxicam	Meloxicam	65	27
Azithromycin	Azithromycin	60	43
Quetiapine Fumarate	Quetiapine Fumarate	59	suppressed
Potassium Chloride	Potassium Chloride	58	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	58	18
Zolpidem Tartrate	Zolpidem Tartrate	57	14
Alfuzosin Hcl Er	Alfuzosin Hcl	55	suppressed
Donepezil Hcl	Donepezil Hcl	53	11
Albuterol Sulfate Hfa	Albuterol Sulfate	52	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	suppressed
Myrbetriq	Mirabegron	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Acyclovir	Acyclovir	46	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	41	27
Torsemide	Torsemide	39	suppressed
Carvedilol	Carvedilol	37	12
Fluticasone Propionate	Fluticasone Propionate	35	16
Triamcinolone Acetonide	Triamcinolone Acetonide	34	23
Glipizide	Glipizide	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Baclofen	Baclofen	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Methylprednisolone	Methylprednisolone	29	19
Mounjaro	Tirzepatide	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Levofloxacin	Levofloxacin	28	16
Montelukast Sodium	Montelukast Sodium	28	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Vancomycin Hcl	Vancomycin Hcl	25	11
Diazepam	Diazepam	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Ondansetron Odt	Ondansetron	23	12
Warfarin Sodium	Warfarin Sodium	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Ondansetron Hcl	Ondansetron Hcl	21	14
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Budesonide Dr	Budesonide	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Cefadroxil	Cefadroxil	18	17
Enalapril Maleate	Enalapril Maleate	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	12
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Cefdinir	Cefdinir	15	13
Cephalexin	Cephalexin	15	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	13
Mupirocin	Mupirocin	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Restasis	Cyclosporine	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error